These Were Big Pharma’s Biggest Winners and Losers in 2016

Biopharma stocks endured a precipitous decline over the course of 2016. But some giants drug making giants made out far better than others, according to a new report based on data from analytics firm Evaluate. To be clear: this analysis is based on market capitalization, and not other critical measures such as clinical trial failures…

http://fortune.com/2017/02/28/big-pharma-winners-losers-2016/

Advertisements